Novak Djokovic, as announced by the CEO of the Danish company, QuantBioRes, has acquired 80% of the shareholding of the company with the aim of developing a medical treatment against Covid-19.
The company from which he acquires the majority of the capital is, according to the Reuters agency, a small danish firm which on its website explains that it has a technology called RRM, for the development of treatments and cures for retroviruses and bacteria resistant to the one caused by the coronavirus.
The Federal Court of Australia confirmed on January 16 the court’s decision to deport Djokovic, which made it impossible for the tennis player to participate in the Melbourne Open. In accordance with the legislation, the Serb can spend three years without traveling to Australia, unless his appeal is successful.
Djokovic traveled to Melbourne on January 5 with a medical exemption for not being vaccinated, having recently been infected with covid-19, although upon arrival the Immigration authorities canceled his visa and detained him.
After learning of the ruling that dismissed his appeal, Djokovic said he felt “deeply disappointed” by the cancellation of his visa. He has become a hero for anti-vaccines.
.
